Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects many women and can cause various health issues, with several treatments available.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Black women with CCCA are more likely to have uterine fibroids.

Over a third of women thought to have non-classical congenital adrenal hyperplasia didn't have it confirmed by genetic tests.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Obese women with PCOS are more likely to have fatty liver disease.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Females are more likely than males to experience long-COVID symptoms and heart issues.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Coping style affects mental health and quality of life in Indian women with PCOS.

The article's findings are uncertain and should be viewed with caution.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Ethnic Indian women with PCOS face significant care gaps, needing better support and information.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.